TG治疗公司 TGTX
$59.83 +$1.85 (+3.18%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $59.75 -0.13%
开盘$57.99
昨收$57.98
当日区间$57.55 – $60.82
成交量2.31M
市值$9.16B
市盈率（TTM）21.8
股息率–
财报
财报日平均波动±17.0%近16次财报
收涨次数9 / 1656% 的概率
最佳反应+30.9%
最差反应-49.3%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 3 Aug 2026 | Pre Market | ±11.7% | -11.26% | 符合区间 |
| 2026/Q1 | 6 May 2026 | Pre Market | ±8.8% | +16.26% | 超出定价预期 |
| 2025/Q4 | 26 Feb 2026 | Pre Market | ±10.5% | +4.18% | 符合区间 |
| 2025/Q3 | 3 Nov 2025 | Pre Market | ±14.5% | -3.13% | 符合区间 |
| 2025/Q2 | 4 Aug 2025 | Pre Market | ±14.6% | -17.99% | 超出定价预期 |
| 2025/Q1 | 5 May 2025 | None | ±13.8% | -13.26% | 符合区间 |
| 2024/Q4 | 3 Mar 2025 | None | ±13.2% | +14.39% | 超出定价预期 |
| 2024/Q3 | 4 Nov 2024 | Pre Market | ±17.9% | -9.44% | 符合区间 |
| 2024/Q2 | 6 Aug 2024 | Pre Market | ±23.0% | +19.58% | 符合区间 |
| 2024/Q1 | 1 May 2024 | Pre Market | ±8.8% | +16.25% | 超出定价预期 |
| 2023/Q4 | 28 Feb 2024 | Pre Market | ±17.6% | +26.74% | 超出定价预期 |
| 2023/Q3 | 1 Nov 2023 | Pre Market | ±16.4% | +30.92% | 超出定价预期 |
| 2023/Q2 | 1 Aug 2023 | Pre Market | ±21.7% | -49.30% | 超出定价预期 |
| 2023/Q1 | 1 May 2023 | Pre Market | ±11.7% | +23.40% | 超出定价预期 |
| 2022/Q4 | 28 Feb 2023 | After Market | ±5.9% | -4.37% | 符合区间 |
| 2022/Q3 | 10 Nov 2022 | After Market | ±20.1% | +10.79% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q2, ended Jun 2026
营收$240.34M+70.3% YoY
营业利润$21.67M-37.8% YoY
净利润$7.78M-72.4% YoY
摊薄每股收益$0.05-70.6% YoY
自由现金流$38.97M+427.0% YoY
经营现金流$39.26M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率82.4%
营业利润率17.1%
净利率55.2%
净资产收益率100.3%
资产收益率37.7%
投入资本回报率49.1%
流动比率4.27
负债/资产比率63.2%
现金及投资$552.25M
总负债$752.53M
净现金（净负债）-$200.28M
自由现金流/营收2.2%
暂无评论——快来第一个聊聊 TGTX。
登录后参与讨论。